Cited by 629Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.

Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

Open access

Gastaldelli, Amalia, Cusi, Kenneth, Pettiti, Maura, Hardies, Jean, Miyazaki, Yoshinori, Berria, Rachele, Buzzigoli, Emma, Sironi, Anna Maria, Cersosimo, Eugenio, Ferrannini, Ele, DeFronzo, Ralph A.·2007·Gastroenterology

DOI 10.1053/j.gastro.2007.04.068

Open this paper in CoChat — free account Open PDF

Abstract

Background and aims Abdominal fat accumulation (visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG).Methods In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 +/- 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-(3)H-glucose) and GNG ((2)H(2)O) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (LF) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging.Results LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% +/- 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 micromol/min/kg(ffm); P = .02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 micromol/min/kg(ffm); P = .02). Basal hepatic IR index (EGP x fasting plasma insulin) was increased in T2DM (NGT, 816 +/- 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P = .007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05).Conclusions Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2007.04.068

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770

Flagged first, then by citations

Show all 43 references

2 of the 43 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Matsuda, 1997, Relationship between insulin sensitivity in adipose tissue, liver, muscle and components of the insulin resistance syndrome, Diabetes, 46, 68A

Sorted by citations

Items 201–300 of 629

Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
Platek, A. E., & Szymańska, A. (2023) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2023.130744 · Cited by 54
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH
Mucinski, J. M., Salvador, A. F., Moore, M. P., Fordham, T. M., Anderson, J. M., Shryack, G. E., Cunningham, R. P., Lastra, G., Gaballah, A. H., Diaz‐Arias, A. A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.017 · Cited by 58
Increased Adipose Tissue Insulin Resistance in Metabolic Syndrome: Relationship to Circulating Adipokines
ADAMS-HUET, B. A., Devaraj, S., Siegel, D., & Jialal, I. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0092 · Cited by 53
Relationship between fatty liver and glucose metabolism: A cross-sectional study in 571 obese children
Bedogni, G., Gastaldelli, A., Manco, M., Col, A. D., Agosti, F., Tiribelli, C., & Sartório, A. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.05.003 · Cited by 53
Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: A cross‐sectional and longitudinal study from the Y ale P ediatric NAFLD cohort
Tricò, D., Galderisi, A., Mari, A., Polidori, D., Galuppo, B., Pierpont, B. M., Samuels, S. L., Santoro, N., & Caprio, S. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14076 · Cited by 52
Effect of resistance training with and without caloric restriction on visceral fat: A systemic review and meta‐analysis
Khalafi, M., Malandish, A., Rosenkranz, S. K., & Ravasi, A. A. (2021) · Obesity Reviews · doi:10.1111/obr.13275 · Cited by 58
Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects
Cersosimo, E., Gastaldelli, A., Cervera, A., Wajcberg, E., Sriwijilkamol, A., Fernandez, M., Zuo, P., Petz, R., Triplitt, C., Musi, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2146 · Cited by 50
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
Doycheva, I., Patel, N. S., Peterson, M. R., & Loomba, R. S. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.10.008 · Cited by 52
Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high‐fat diet
Cansby, E., Amrutkar, M., Mannerås-Holm, L., Nerstedt, A., Reyahi, A., Stenfeldt, E., Borén, J., Carlsson, P., Smith, U., Zierath, J. R., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-228494 · Cited by 49
Viewpoints on the Way to a Consensus Session
Perseghin, G. (2009) · Diabetes Care · doi:10.2337/dc09-s303 · Cited by 50
Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
Baran, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14219 · Cited by 51
Long‐term dietary supplementation with low‐dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet‐induced obesity
Kim, Y., Choi, M., Woo, J. T., Jeong, M. J., Kim, S. R., & Jung, U. J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600889 · Cited by 50
The Therapeutic Potential of Brown Adipocytes in Humans
Porter, C. C., Chondronikola, M., & Sidossis, L. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00156 · Cited by 52
Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease
Kato, K., Takamura, T., Takeshita, Y., Ryu, Y., Misu, H., Ota, T., Tokuyama, K., Nagasaka, S., Matsuhisa, M., Matsui, O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092170 · Cited by 47
Strong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects
Abdul‐Ghani, M. A., Matsuda, M., & DeFronzo, R. A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02597.x · Cited by 48
The Transcriptome of Human Epicardial, Mediastinal and Subcutaneous Adipose Tissues in Men with Coronary Artery Disease
Guauque-Olarte, S., Gaudreault, N., Piché, M., Fournier, D., Mauriège, P., Mathieu, P., & Bossé, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019908 · Cited by 48
Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids
Spahis, S., Álvarez, F., Ahmed, N., Dubois, J., El-Jalbout, R., Paganelli, M., Grzywacz, K., DELVIN, E. E., Peretti, N., & Levy, E. H. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.025 · Cited by 49
Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy
彭新桂, X.-G. P., Ju, S., 秦雨姣, Y. Q., 方芳, F. F., Cui, X., 刘国庆, G. L., 倪以成, Y. N., & Teng, G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d016691 · Cited by 47
Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study
Huerta, J. M., Tormo, M.-J., Chirlaque, M., Gavrila, D., Amiano, P., Arriola, L., Ardanáz, E., Rodríguez, L., Sánchez, M., Méndez, M. A., et al. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-7 · Cited by 52
Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats
Brockman, D. A., Chen, X., & Gallaher, D. D. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-100 · Cited by 46
Bariatric surgery and the liver—Mechanisms, benefits, and risks
Lefere, S., Onghena, L., Vanlander, A., Nieuwenhove, Y. V., Devisscher, L., & Geerts, A. M. (2021) · Obesity Reviews · doi:10.1111/obr.13294 · Cited by 49
Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization
Cheng, J., Liu, C., Hu, K., Greenberg, A. S., Wu, D., Ausman, L. M., McBurney, M. W., & Wang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.004 · Cited by 45
The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target
Willmes, D. M., Kurzbach, A., Henke, C., Schumann, T., Zahn, G., Heifetz, A., Jordan, J., Helfand, S. L., & Birkenfeld, A. L. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.003 · Cited by 45
Dysregulated lipid storage and its relationship with insulin resistance and cardiovascular risk factors in non-obese Asian patients with type 2 diabetes
Rattarasarn, C. (2018) · Adipocyte · doi:10.1080/21623945.2018.1429784 · Cited by 47
Natural History of NAFLD
Pais, R., & Maurel, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061161 · Cited by 47
Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
Newton, K. P., Wilson, L., Crimmins, N. A., Fishbein, M. H., Molleston, J. P., Xanthakos, S. A., Behling, C., Schwimmer, J. B., Garner, D., Hertel, P. M., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.028 · Cited by 45
Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long–Evans Tokushima fatty rats
Nishimura, N., Kitade, M., Noguchi, R., Namisaki, T., Moriya, K., Takeda, K., Okura, Y., Aihara, Y., Douhara, A., Kawaratani, H., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1200-6 · Cited by 44
Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass
Gastaldelli, A., Iaconelli, A., Gaggini, M., Magnone, M. C., Veneziani, A., Rubino, F., & Mingrone, G. (2016) · Diabetes Care · doi:10.2337/dc15-2823 · Cited by 46
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
Johansson, L., Hockings, P. D., JOHNSSON, E. K., Dronamraju, N., Maaske, J., García‐Sánchez, R., & Wilding, J. P. H. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14004 · Cited by 43
The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis—Dysregulation by the Liver
London, A., Lundsgaard, A., Kiens, B., & Bojsen-Møller, K. N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030390 · Cited by 46
Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis
Perseghin, G. (2011) · Diabetes Care · doi:10.2337/dc11-s249 · Cited by 45
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( EDICT )
Lavynenko, O., Abdul‐Ghani, M., Alatrach, M., Puckett, C., Adams, J., Abdelgani, S., Alkhouri, N., Triplitt, C., Clarke, G. D., Vasquez, J. A., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14650 · Cited by 44
Impact of prolonged fasting on insulin secretion, insulin action, and hepatic versus whole body insulin secretion disposition indices in healthy young males
Jørgensen, S. W., Hjort, L., Gillberg, L., Justesen, L., Madsbad, S., Brøns, C., & Vaag, A. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2020 · Cited by 43
Fatty liver disease: the hepatic manifestation of metabolic syndrome
Gastaldelli, A. (2010) · Hypertension Research · doi:10.1038/hr.2010.60 · Cited by 42
Cardiovascular risk and mortality in patients with active and treated hypercortisolism
Li, D., El Kawkgi, O. M., Henriquez, A. F., & Bancos, I. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.03 · Cited by 42
Insulin Clearance in Obesity and Type 2 Diabetes
Koh, H. E., Cao, C., & Mittendorfer, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020596 · Cited by 52
Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile
Michaliszyn, S. F., Lee, S., Tfayli, H. M., & Arslanian, S. A. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.08.015 · Cited by 42
How to measure hepatic insulin resistance?
Choukem, S. P., & Gautier, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74602-0 · Cited by 43
Ethnic differences in glucose disposal, hepatic insulin sensitivity, and endogenous glucose production among African American and European American women
Ellis, A., Alvarez, J., Granger, W., Ovalle, F., & Gower, B. (2011) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2011.09.011 · Cited by 41
Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes
Kim, G., Jo, K., Kim, K. J., Lee, Y., Han, E., Yoon, H.-J., Wang, H. J., Kang, E. S., & Yun, M. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0310-4 · Cited by 40
Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects
Salinari, S., Carr, R. D., Guidone, C., BERTUZZI, A., Cercone, S., Riccioni, M. E., Manto, A., Ghirlanda, G., & Mingrone, G. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00559.2012 · Cited by 40
Abdominal Obesity and Insulin Resistance in People Exposed to Moderate-to-High Levels of Dioxin
Chang, J.-W., Chen, H., Su, H.-J. J., & Lee, C.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145818 · Cited by 40
WISP1 promotes non‐alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling
Jung, T. W., Kang, C. M., Goh, J., Chae, S. I., Kim, H., Lee, T. J., El‐Aty, A. M. A., & Jeong, J. H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26449 · Cited by 40
Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders
Lan, Y., Lou, J., Lyu, W., & Zhang, B. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819877300 · Cited by 47
Relationships of body composition and liver fat content with insulin resistance in obesity‐matched adolescents and adults
Linder, K., Springer, L., Machann, J., Schick, F., Fritsche, A., Häring, H., Blumenstock, G., Ranke, M. B., Stefan, N., Binder, G., et al. (2013) · Obesity · doi:10.1002/oby.20685 · Cited by 39
Abdominal MRI at 3.0 T: LAVA‐flex compared with conventional fat suppression T1‐weighted images
Li, X. H., Zhu, J., Zhang, X. M., Ji, Y. F., Chen, T. W., Huang, X. H., Yang, L., & Zeng, N. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24329 · Cited by 39
Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
Iizuka, T., Iemitsu, K., Takihata, M., Takai, M., Nakajima, S., Minami, N., Umezawa, S., Kanamori, A., Takeda, H., Kawata, T., et al. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2417w · Cited by 39
Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111016 · Cited by 38
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
Carli, F., Sabatini, S., Gaggini, M., Sironi, A. M., Bedogni, G., & Gastaldelli, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914651 · Cited by 37
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease
Driuchina, A., Hintikka, J. E., Lehtonen, M., Keski‐Rahkonen, P., O’Connell, T. M., Juvonen, R. O., Kuula, J., Hakkarainen, A., Laukkanen, J. A., Mäkinen, E., et al. (2023) · mBio · doi:10.1128/mbio.02663-22 · Cited by 39
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
Guglielmi, V., Bettini, S., Sbraccia, P., Busetto, L., Pellegrini, M., Yumuk, V., Colao, A. M. L., Ghoch, M. E., & Muscogiuri, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00502-7 · Cited by 41
Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
Xiao, Y., Zhang, X., Yi, D., Qiu, F., Wu, L., Tang, Y., & Wang, N. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1225946 · Cited by 37
Coordinated Defects in Hepatic Long Chain Fatty Acid Metabolism and Triglyceride Accumulation Contribute to Insulin Resistance in Non-Human Primates
Kamath, S., Chávez, A. O., Gastaldelli, A., Casiraghi, F., Halff, G. A., ABRAHAMIAN, G. A., Davalli, A. M., Bastarrachea, R. A., Comuzzie, A. G., Guardado‐Mendoza, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027617 · Cited by 36
Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism
Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Orlandi, A., Scioli, M. G., Pastore, D., Andreadi, A., Sbraccia, P., Tesauro, M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9685607 · Cited by 36
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 37
Perilipin Polymorphism Interacts with Dietary Carbohydrates to Modulate Anthropometric Traits in Hispanics of Caribbean Origin
Smith, C. E., Tucker, K. L., Yiannakouris, N., García‐Bailo, B., Mattei, J., Lai, C., Parnell, L. D., & Ordovás, J. M. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.1852 · Cited by 36
Mediterranean Diet, Glucose Homeostasis, and Inflammasome Genetic Variants: The CORDIOPREV Study
Roncero‐Ramos, I., Rangel-Zúñiga, O. A., López-Moreno, J., Alcala-Diaz, J. F., Pérez‐Martínez, P., Jiménez-Lucena, R., Castano, J. P., Roche, H. M., Delgado‐Lista, J., Ordovás, J. M., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700960 · Cited by 37
Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
Enooku, K., Kondo, M., Fujiwara, N., Sasako, T., Shibahara, J., Kado, A., Okushin, K., Fujinaga, H., Tsutsumi, T., Nakagomi, R., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1472-0 · Cited by 35
Nuclear Receptors Reverse McGarry's Vicious Cycle to Insulin Resistance
Moore, D. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.016 · Cited by 37
Acute hyperenergetic, high-fat feeding increases circulating FGF21, LECT2, and fetuin-A in healthy men
Willis, S. A., Sargeant, J. A., Yates, T., Takamura, T., Takayama, H., Gupta, V., Brittain, E., Crawford, J., Parry, S. A., Thackray, A. E., et al. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz333 · Cited by 34
Influence of Liver Triglycerides on Suppression of Glucose Production by Insulin in Men
Jin, E. S., Szuszkiewicz-Garcia, M., Browning, J. D., Baxter, J. D., Abate, N. I., & Malloy, C. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2404 · Cited by 34
A Meal High in Saturated Fat Evokes Postprandial Dyslipemia, Hyperinsulinemia, and Altered Lipoprotein Expression in Obese Children With and Without Nonalcoholic Fatty Liver Disease
Mager, D. R., Mazurak, V. C., Rodriguez‐Dimitrescu, C., Vine, D. F., Jetha, M. M., Ball, G. D. C., & Yap, J. Y. K. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112467820 · Cited by 34
Mitochondrial fusion/fission process involved in the improvement of catalpol on high glucose-induced hepatic mitochondrial dysfunction
Xu, Z., Zhang, L., Li, X., Jiang, Z., Sun, L., Zhao, G., Zhou, G., Zhang, H., Shang, J., & Wang, T. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv061 · Cited by 34
A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease
Sangouni, A. A., Ghavamzadeh, S., & Jamalzehi, A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.013 · Cited by 34
Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity
Levine, J. A., Han, J. M., Wolska, A. T., Wilson, S. R., Patel, T. P., Remaley, A. T., Periwal, V., Yanovski, J. A., & Demidowich, A. P. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.012 · Cited by 35
Potential Role of Natural Plant Medicine Cyclocarya paliurus in the Treatment of Type 2 Diabetes Mellitus
Wang, H., Tang, C. C., Gao, Z., Huang, Y., Zhang, B., Wei, J., Zhao, L., & Tong, X. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1655336 · Cited by 34
Visceral fat loss induced by a low‐calorie diet: a direct comparison between women and men
Gasteyger, C., Larsen, T. M., Vercruysse, F., Pedersen, D. C., Toubro, S., & Astrup, A. V. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01025.x · Cited by 34
Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
Banitalebi, E., Faramarzi, M., Nasiri, S., Ghahfarrokhi, M. M., & Rabiee, V. (2019) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0086 · Cited by 35
Abdominal fat: does it predict the development of type 2 diabetes?
Gastaldelli, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1118 · Cited by 32
Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation
Luo, K., Huang, W., Qiao, L., Zhang, X., Yan, D., Ning, Z.-Y., Ma, C., Dang, H., Wang, D., Guo, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.017 · Cited by 33
Reduced Insulin Clearance Differently Relates to Increased Liver Lipid Content and Worse Glycemic Control in Recent-Onset Type 2 and Type 1 Diabetes
Zaharia, O., Antoniou, S., Bobrov, P., Karusheva, Y., Bódis, K. B., Kupriyanova, Y., Schrauwen‐Hinderling, V. B., Gastaldelli, A., Szendroedi, J., Wagner, R. J., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1267 · Cited by 34
Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Kovalic, A. J., Banerjee, P., Tran, Q. T., Singal, A. K., & Satapathy, S. K. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.001 · Cited by 32
Association between cardiometabolic risk factors and body mass index, waist circumferences and body fat in a Zanzibari cross-sectional study
Nyangasa, M. A., Buck, C., Kelm, S., Sheikh, M. A., Brackmann, L. K., & Hebestreit, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025397 · Cited by 32
Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance
KAHN, D. E., & Bergman, B. C. (2022) · Diabetes · doi:10.2337/dbi21-0020 · Cited by 34
Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study
Watanabe, T., Tamura, Y., Kakehi, S., Funayama, T., Gastaldelli, A., Takeno, K., Kawaguchi, M., Yamamoto, R., Sato, F., Ikeda, S., et al. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12262 · Cited by 31
The effect of exercise training on adipose tissue insulin sensitivity: A systematic review and meta‐analysis
Engin, B., Willis, S. A., Malaikah, S., Sargeant, J. A., Yates, T., Gray, L. J., Aithal, G. P., Stensel, D. J., & King, J. A. (2022) · Obesity Reviews · doi:10.1111/obr.13445 · Cited by 31
Fibrogenesis in nonalcoholic steatohepatitis
Minicis, S. D., & Svegliati‐Baroni, G. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.28 · Cited by 32
Improvement of Liquid Fructose-Induced Adipose Tissue Insulin Resistance by Ginger Treatment in Rats Is Associated with Suppression of Adipose Macrophage-Related Proinflammatory Cytokines
Wang, J., Gao, H., Ke, D., Zuo, G., Yang, Y., Yamahara, J., & Li, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/590376 · Cited by 33
Why Does NAFLD Predict Type 2 Diabetes?
Lattuada, G., Ragogna, F., & Perseghin, G. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0190-2 · Cited by 31
Insulin resistance, adipose depots and gut: Interactions and pathological implications
Gastaldelli, A., Natali, A., Vettor, R., & Corradini, S. G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.013 · Cited by 32
A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves β-cell function in individuals with impaired fasting glucose
Gower, B. A., Goree, L. L., Chandler-Laney, P. C., Ellis, A. C., Casazza, K., & Granger, W. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.07.011 · Cited by 31
Modulation of Liver Fibrosis by Adipokines
Marra, F., Navari, N., Vivoli, E., Galastri, S., & Provenzano, A. (2011) · Digestive Diseases · doi:10.1159/000329799 · Cited by 30
Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells
Liu, Y., Liao, L., Chen, Y., & Han, F. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10139 · Cited by 30
The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review
Semnani-Azad, Z., Mejia, S. B., Connelly, P., Bazinet, R., Retnakaran, R., Jenkins, D., Harris, S., & Hanley, A. (2021) · Obesity Reviews · doi:10.1111/obr.13257 · Cited by 26
Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
Foss‐Freitas, M. C., Akıncı, B., Neidert, A., Bartlett, V. J., Hurh, E., Karwatowska‐Prokopczuk, E., & Oral, E. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01589-4 · Cited by 31
Duodenal PKC-δ and Cholecystokinin Signaling Axis Regulates Glucose Production
Breen, D. M., Yue, J. T. Y., Rasmussen, B. A., Kokorovic, A., Cheung, G. W. C., & Lam, T. K. T. (2011) · Diabetes · doi:10.2337/db11-0852 · Cited by 30
Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
Alsabaani, A. A., Mahfouz, A. A., Awadalla, N. J., Musa, M. J., & Humayed, S. M. A. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112521 · Cited by 30
Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
Shi, T., Kobara, H., Oura, K., & Masaki, T. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s274933 · Cited by 29
Cardiometabolic implications of adipose tissue aging
Ahmed, B., Farb, M. G., & Gokce, N. (2024) · Obesity Reviews · doi:10.1111/obr.13806 · Cited by 32
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis
Sabatini, S., Sen, P., Carli, F., Pezzica, S., Rosso, C., Lembo, E., Verrastro, O., Daly, A. K., Govaere, O., Cockell, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101820 · Cited by 32
Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes
Miya, A., Nakamura, A., Miyoshi, H., Takano, Y., Sunagoya, K., Hayasaka, K., Shimizu, C., Terauchi, Y., & Atsumi, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00081 · Cited by 28
A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach
Sangouni, A. A., & Ghavamzadeh, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.063 · Cited by 28
Ectopic Fat Storage, Insulin Resistance, and Hypertension
Sironi, A. M., Sicari, R., Folli, F. B., & Gastaldelli, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798157720 · Cited by 29
A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis
Hickman, I. J. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000300 · Cited by 27
Chronic Peripheral Hyperinsulinemia in Type 1 Diabetic Patients After Successful Combined Pancreas-Kidney Transplantation Does Not Affect Ectopic Lipid Accumulation in Skeletal Muscle and Liver
Stadler, M., Anderwald, C. H., Pacini, G., Zbýň, Š., Promintzer‐Schifferl, M., Mandl, M., Bischof, M. G., Gruber, S., Nowotny, P., Luger, A., et al. (2009) · Diabetes · doi:10.2337/db09-0354 · Cited by 28
Alleviation of fatty liver in a rat model by enhancing N1-methylnicotinamide bioavailability through aldehyde oxidase inhibition
Takeuchi, K., Yokouchi, C., Goto, H., Umehara, K., Yamada, H., & Ishii, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.008 · Cited by 29
Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention
Jonker, J. T., de Heer, P., Engelse, M. A., van Rossenberg, E. H., Klessens, C. Q. F., Baelde, H. J., Bajema, I. M., Koopmans, S. J., Coelho, P. G., Streefland, T. C. M., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx243 · Cited by 27
Adipocyte hypertrophy associates with in vivo postprandial fatty acid metabolism and adipose single-cell transcriptional dynamics
Ye, R. Z., Montastier, É., Frisch, F., Noll, C., Allard‐Chamard, H., Gévry, N. Y., Tchernof, A., & Carpentier, A. C. (2023) · iScience · doi:10.1016/j.isci.2023.108692 · Cited by 27
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution
Bozzetto, L., Prinster, A., Mancini, M., Giacco, R., Natale, C. D., Salvatore, M., Riccardi, G., Rivellese, A. A., & Annuzzi, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02372.x · Cited by 28
The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study
London, A., Richter, M. M., Sjøberg, K. A., Albrechtsen, N. J. W., Považan, M., Drici, L., Schaufuss, A., Madsen, L., Øyen, J., Madsbad, S., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.06.006 · Cited by 26

Authors: Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., & DeFronzo, R. A.
Affiliations: The University of Texas at San Antonio Health Science Center (US)
Istituto di Fisiologia Clinica (IT)
University of Pisa (IT)
Corresponding author: Gastaldelli, Amalia
ORCID: Gastaldelli, Amalia
Cusi, Kenneth
Sironi, Anna Maria
Ferrannini, Ele
DeFronzo, Ralph A.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2007-08
Volume: 133
Issue: 2
Pages: 496-506
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2007.04.068
OpenAlex: W2136226749
Cited by: 629
References: 43
Citations by year: 2026: 25 · 2025: 25 · 2024: 33 · 2023: 40 · 2022: 40 · 2021: 40 · 2020: 27 · 2019: 41 · 2018: 36 · 2017: 47 · 2016: 34 · 2015: 26 · 2014: 39 · 2013: 37 · 2012: 33
FWCI: 16.58
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
National Center for Research Resources (M01RR01346, M01RR001346)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: hepatic insulin resistance, visceral fat, liver fat, abdominal fat accumulation, type 2 diabetes, obesity, hepatic glucose production, gluconeogenesis, hepatic steatosis, hyperinsulinemic-euglycemic clamp, subcutaneous adipose tissue, hepatic lipid accumulation, hepatic lipogenesis, hepatic lipolysis
MeSH terms: Adult, Aging, Blood Glucose, Diabetes Mellitus, Type 2, Female, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Glucose Clamp Technique, Body Mass Index, Abdominal Fat, Glycogenolysis, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks